Abstract

Background and objective: Ovulatory dysfunction is a common cause of infertility. This study aimed to determine if letrozole is more efficient than clomiphene for the induction of ovulation in a group of un ovulatory infertile women. Methods: A prospective, comparative study was conducted at the Fertility Center Out-patient Department of Maternity Teaching Hospital, Erbil city, Kurdistan Region, Iraq, from May 2011, to May 2012. Hundred infertile couples having anovulatory infertility were included in the study; 50 women (146 cycles) were given letrozole 5 mg for three cycles, and 50 (148 cycles) women were put on clomiphene citrate (CC) 100 mg for three cycles, from day 2 to day 6 of the menstrual cycle. The diagnosis of pregnancy was confirmed by ultrasound. Two-tailed independent t-test was used to compare means, while proportions were compared with the Chi-Square test. Results: Ovulation occurred in 131/150 women in the clomiphene citrate group and 124/150 women in the letrozole group. The total number of mature follicles for clomiphene citrate was 1.44 ±0.56mm, while it was 1.13 ±0.32mm for letrozole, which was highly significant (P = 0.001). Endometrial thickness at the time of hCG administration for clomiphene citrate versus letrozole was (7.95 ±1.53mm versus 9.37 ± 2.04mm, P = 0.001) respectively. The pregnancy rate was 16/148 cycles in the clomiphene citrate group and 20/146 cycles in the letrozole group. Conclusion: Letrozole and clomiphene citrate are equally effective for the induction of ovulation and achieving pregnancy in patients with anovulatory infertility.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.